ProteomeXchange’s 2026 update shows that global proteomics data sharing continues to accelerate, with more than 64,000 ...

Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...

OpenAI has released GPT-Rosalind, a large language model fine-tuned specifically for life sciences research, marking the ...

Protein engineering is a field primed for artificial intelligence research. Each protein is made up of amino acids; to ...

The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

OpenAI has moved deeper into the scientific market with the launch of GPT-Rosalind, a specialist artificial intelligence model designed for biology, drug discovery and translational medicine, marking ...

OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...

BD200 demonstrated superior uptake and cellular cytotoxicity when compared to approved drugs targeting either Trop-2 or ...

At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous ...

A research team has delivered one of the most comprehensive molecular portraits yet of Anthurium, a globally prized ...

Efforts to identify and evaluate next-generation therapeutics for pediatric brain tumors are easily stymied by the quality and availability of laboratory models for research. To address this issue, ...